Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

GILD - Gilead Sciences Inc

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by bigbear0083, Mar 31, 2016.

  1. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    I put up 2 charts last few days. This stock is headed much higher. Don’t listen to the loser "I think we're headed for the $50's crowd"
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,293
    Likes Received:
    2,268
    You could at least copy and paste StockTwits comments that don't make you look like a liar on here to people who aren't aware you're copy pasting. No charts from you.
     
  3. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    Zack whose success rate is 1.12% has downgrade this share to sell, that is why it is down. Fyi: zack was bullish when it's 90. I honestly hate this stock, because this one is only down in my portfolio, but still at this point there is more upside then downside
     
  4. Russell

    Russell New Member

    Joined:
    Apr 5, 2017
    Messages:
    2
    Likes Received:
    0
    I'm very long on GILD and agree it is way undervalued. Future EPS puts its value well into $100+ range. Financials are good, sentiment is bad. GILD is currently one of my top 3 picks at wayundervalued.com

    Holding GILD and being patient could really pay off in the long term. Enjoy the dividend in the meantime. When sentiment changes, there's lots of upside here..
     
    #24 Russell, Apr 5, 2017
    Last edited: Apr 6, 2017
  5. EcoWOLFrb

    EcoWOLFrb New Member

    Joined:
    Jul 6, 2016
    Messages:
    24
    Likes Received:
    11
    Looks like maybe breaking the downward trend? They have cash on hand, value play. What do you guys think?
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    7,074
    Likes Received:
    2,094
    Day 3 of the big move!
     
  7. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    704
    Likes Received:
    62
    HIV fight advances with new drug cocktails, fresh vaccine hopes
     
  8. bigbear0083

    bigbear0083 Content Manager
    Staff Member

    Joined:
    Mar 29, 2016
    Messages:
    22,799
    Likes Received:
    8,264
    ER after the close today.

    Here are the consensus & whisper #'s:

    [​IMG]
     
  9. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    27
    Gilead stock looks slightly undervalued at this point because the market is undervaluing Gilead’s HIV and oncology portfolios. The company also shows significant potential in the immunology/NASH area.

    Biktarvy revenues were only $35 million this past quarter. However, this could easily become Gilead’s largest HIV product, hitting a $5 billion mark.
     
  10. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    27
    Gilead's tenofovir molecule formed the heart of the firm's $14 billion HIV franchise. Combo pills offer patients convenience and affordability, as they are less likely to miss doses and develop drug resistance, and they only need to make one copayment.
     
  11. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    7,293
    Likes Received:
    2,268
    I haven't followed this stock nearly close enough, but with Remdesivir or whatever it's called, this pullback looks like a decent opportunity to hop in. Might take a chance around $76ish (current 50MA). I'll have to pay closer attention to Covid treatment/vaccine talk though if I hop in to this one.

    upload_2020-5-6_10-33-12.png
     
  12. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    829
    Likes Received:
    431
     
  13. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    829
    Likes Received:
    431
    Clinical tests being done as we speak. News everywhere. Don't let a good crisis go to waste.
     
  14. A55

    A55 Active Member

    Joined:
    Jun 28, 2020
    Messages:
    165
    Likes Received:
    25
    Gilead is a good company and the stock pays a dividend. Don't look for massive growth. It's not going over $100 anytime soon.
     
  15. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    829
    Likes Received:
    431
    How about $90 on some good clinical trial results? What say you?
     
  16. A55

    A55 Active Member

    Joined:
    Jun 28, 2020
    Messages:
    165
    Likes Received:
    25
    Gilead is already making money with HIV treatments. It looks like they lowballed Remdesivir pricing on purpose. $90 is on the horizon for long term investments. Conservatively in 5 years. By then, you should also dividend increases.

    You never know what the future holds. If a vaccine materializes, look for joint marketing and distribution, a merger, or a spin-off into a corona virus focused company. 1stop shopping for hospitals. 1vendor with all corona related supplies.
     
    T0rm3nted likes this.
  17. A55

    A55 Active Member

    Joined:
    Jun 28, 2020
    Messages:
    165
    Likes Received:
    25
  18. A55

    A55 Active Member

    Joined:
    Jun 28, 2020
    Messages:
    165
    Likes Received:
    25
  19. A55

    A55 Active Member

    Joined:
    Jun 28, 2020
    Messages:
    165
    Likes Received:
    25
    Those bookshelves are full of self help books Screenshot_2020-06-30-15-07-02.png Screenshot_2020-06-30-15-13-08.png
     
  20. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,990
    Likes Received:
    2,632
    That argument from the WSJ about Remdesivir, didn't work for Sovaldi.
    People had the option of paying $1000/pill for Sovaldi (I think it was 49 pills in 49 days), or not. Of course if you didn't take Sovaldi you risked losing a limb due to liver disease or developing liver cancer, and dying in pain. $1000 seems like a small price to pay to avoid those outcomes. But people got incensed anyway. Because, thanks to the Geneva convention for drug prices, Gilead had to provide low-cost pills to 3rd world countries so poor peoples could get the health benefits too. So while people were paying $1000/pill in the US, you could find similar pills for $5 in India.
     

Share This Page